Alector (ALEC) Cash from Financing Activities (2018 - 2026)

Alector (ALEC) reported Cash from Financing Activities of $25000.0 for Q1 2026, down 99.54% quarter-over-quarter from $5.4 million in Q4 2025.

Alector (ALEC) Cash from Financing Activities (2018 - 2026) Analysis & Trends

Alector (ALEC) has 9 years of Cash from Financing Activities data on file, last reported at $25000.0 in Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $25000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $20.2 million (up 94.02% YoY), and the FY2025 annual result was $20.2 million, down 75.21% from the prior year.
  • Cash from Financing Activities eased to $25000.0 in Q1 2026 per ALEC's latest filing, from $5.4 million in the prior quarter.
  • Over five years, Cash from Financing Activities peaked at $71.1 million in Q1 2024 and troughed at $25000.0 in Q1 2026.
  • A 5-year average of $7.8 million and a median of $893500.0 in 2022 frame the typical range for Cash from Financing Activities.
  • The sharpest annual moves came in 2022 and 2024: Cash from Financing Activities slumped 96.7% in 2022, then surged 6490.18% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $636000.0 in 2022, then decreased by 7.23% to $590000.0 in 2023, then surged by 1558.98% to $9.8 million in 2024, then sank by 44.91% to $5.4 million in 2025, then sank by 99.54% to $25000.0 in 2026.
  • Business Quant data shows ALEC's Cash from Financing Activities at $25000.0 in Q1 2026, $5.4 million in Q4 2025, and $14.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Alector 193.53 Mn -12.98 Mn - 25,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 25,000.00
Mar 31, 2026 25,000.00
Dec 31, 2025 5.39 Mn
Dec 31, 2025 5.39 Mn
Sep 30, 2025 14.70 Mn
Sep 30, 2025 14.70 Mn
Jun 30, 2025 122,000.00
Jun 30, 2025 122,000.00
Dec 31, 2024 9.79 Mn
Dec 31, 2024 9.79 Mn
Jun 30, 2024 644,000.00
Jun 30, 2024 644,000.00
Mar 31, 2024 71.11 Mn
Mar 31, 2024 71.11 Mn
Dec 31, 2023 590,000.00
Dec 31, 2023 590,000.00
Jun 30, 2023 881,000.00
Jun 30, 2023 881,000.00
Mar 31, 2023 1.08 Mn
Mar 31, 2023 1.08 Mn